Swissmedic Clears Ekterly®: A Breakthrough in Medical Devices
Swissmedic has granted its first authorization to Ekterly®, marking a significant milestone in the development of medical devices. As of […]
Swissmedic has granted its first authorization to Ekterly®, marking a significant milestone in the development of medical devices. As of […]
On February 12, 2026, the U S Food and Drug Administration began accepting requests to participate in the FDA PreCheck
Meta description: The FDA has approved a first of its kind device for locally advanced pancreatic cancer, marking a regulatory
Meta description: This update enhances patient and clinician risk communication by presenting clear safety guidance across six menopausal hormone therapy
Published February 15, 2026, this regulatory update covers a Florida State University trial testing high intensity inspiratory muscle training for
This report covers a nonpharmacological approach using a ShotBlocker device to reduce pain and fear during breast cancer hormone injections,
This regulatory update reviews the COMPETE LM trial listing for drug coated balloon enhanced provisional stenting in complex left main
Context: February 15, 2026 frames this update on a completed trial comparing Miswak Salvadora persica with a toothbrush for plaque
This report examines a three arm gingival depigmentation trial evaluating conventional methods, diode laser and microneedling with topical silymarin, with
Meta description: A completed study from Kafrelsheikh University evaluates decompression alone versus decompression with fusion for degenerative spondylolisthesis with lumbar